Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOI, etc.
In recent years, numerous studies have demonstrated that grain proteins and peptides derived from their enzymatic hydrolysis such as dipeptidyl peptidase-4 (DPP-Ⅳ), glucagon-like peptide-1 (GLP-1), peptide YY (PYY) and related enzymes can act on the therapeutic targets for type 2 diabetes mellitus (T2DM) and thereby improve T2DM. This article gives a summary of recent research on the beneficial effect of grain proteins and peptides on T2DM, and discusses future prospects for the application of grain proteins and peptides in T2DM treatment.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Comments on this article